Our Products



E-Eye is developed and manufactured in France by E-SWIN. E-Eye is a technological treatment device for Meibomian Gland Dysfunction – the 2nd most common E-Eye disease worldwide.

E-Eye is specially certified to treat MGD, using the patented IRPL® technology, also developed by E-SWIN. A short treatment protocol (D0/D15/D45) provides long-lasting results from 6 months to 3 years.


© 2016 GMEDCO. All Rights Reserved.
Powered by Whyte Company